摘要
目的 :探讨急性心肌梗死伴心功能KillipⅡ～Ⅲ级患者 3 0天内行经皮冠状动脉介入治疗 (PCI)对预后的影响。方法 :168例急性心肌梗死患者根据心功能Killip分级分为心功能KillipⅠ级组 91例 ,其中接受PCI治疗 3 8例 ;心功能KillipⅡ～Ⅲ级组 77例 ,其中接受PCI治疗 44例。分别比较第 1个月、第 2～ 12个月患者死亡率。结果 :在心功能KillipⅡ～Ⅲ级组中 ,接受PCI治疗患者第 1个月、第 2～ 12个月死亡率较非PCI治疗患者明显下降 ( 6 8%vs.18 2 %、9 1%vs.12 1% ) ,均有显著性差异 (P <0 0 5～ 0 0 1)。心功能KillipⅠ级组中 ,接受PCI治疗患者第 1个月死亡率较非PCI治疗患者下降 ( 2 6%vs .5 7% ) ,有显著性差异 (P <0 0 5 ) ,但第 2～ 12个月死亡率较非PCI治疗患者无显著差别。结论 :急性心肌梗死伴心功能KillipⅡ～Ⅲ级患者 1个月内行PCI治疗能减少死亡率 。
Objective: The aim of this study was to assess the efficacy percutaneous coronary intervention of (PCI) in acute myocardial infarction with Killip class Ⅱ Ⅲ within 1 month of acute myocardial infarction (AMI) onset Methods: One hundred sixty eight patients with AMI were divided into 2 groups according to their admission Killip class:91 in group Killip class Ⅰ,of whom 38 underwent PCI and 53 were treated with medicine,and 77 in group Killip class Ⅱ Ⅲ,of whom 44 underwent PCI and 33 were treated with medicine The mortality rate within 1 month and from 2 to 12 months were compared between groups.Results: Patients in group Killip classⅡ Ⅲ who underwent PCI had lower mortality rate than those who were treated with medicine during 1 month and 2 to 12 months(6 8% vs.18 2% and 9 1% vs.12 1%, p <0 05-0 01).In group Killip class Ⅰ,patients who underwent PCI had lower mortality rate than those who were treated with medicine with 1 month(2 6% vs.5 7%, p <0 05),but there was no significant differience between groups during the peiod of 2 to 12 months.Conclusion: Patients with AMI in Killip class Ⅱ Ⅲ have lower motality rate and may benefit from PCI performed within 1 month of AMI onset.
出处
《中国循环杂志》
CSCD
北大核心
2003年第1期7-9,共3页
Chinese Circulation Journal
